Detalles de la búsqueda
1.
Combination of HAI-FUDR and Systemic Gemcitabine and Cisplatin in Unresectable Cholangiocarcinoma: A Dose Finding Single Center Study.
Oncology
; 99(5): 300-309, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657549
2.
High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.
BMC Cancer
; 20(1): 166, 2020 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32111181
3.
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II Study.
Biol Blood Marrow Transplant
; 24(4): 694-699, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29246820
4.
18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study.
BMC Cancer
; 18(1): 548, 2018 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29743108
5.
Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.
BMC Cancer
; 18(1): 72, 2018 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29325521
6.
R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience.
Ann Hematol
; 97(2): 277-287, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29147847
7.
Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients.
J Clin Apher
; 32(1): 21-26, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27001243
8.
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.
Br J Haematol
; 174(2): 255-63, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27018242
9.
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial.
BMC Cancer
; 16(1): 812, 2016 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27756258
10.
Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience.
Digestion
; 94(1): 1-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27318857
11.
Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 21(1): 74-80, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25278456
12.
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma.
Blood
; 132(19): 2097-2100, 2018 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30237154
13.
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial.
EClinicalMedicine
; 66: 102318, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38024477
14.
A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma.
Oncology
; 82(6): 333-40, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22677881
15.
Greek physiotherapists' contemporary knowledge and practice for lateral elbow tendinopathy: An online survey.
Musculoskelet Sci Pract
; 57: 102502, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35030537
16.
Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells.
Int J Cancer
; 129(4): 832-8, 2011 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21710545
17.
Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
Ann Surg Oncol
; 18(7): 1924-31, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21207165
18.
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim.
Ann Hematol
; 90(1): 89-94, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20706722
19.
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors.
Nat Commun
; 12(1): 3807, 2021 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34155211
20.
Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06).
Oncologist
; 15(3): 285-92, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20203173